Act Two Investors »

AstraZeneca shares owned by Act Two Investors

Quarter-by-quarter ownership of AstraZeneca (AZN) shares owned by Act Two Investors from 13F filings

Historical chart of Act Two Investors investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by Act Two Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by Act Two Investors

Quarter filed Position value Share count Share price at filing
2024-03-31 $21M 304k 67.75

More positions owned by Act Two Investors

Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Nxp Semiconductors N V (NXPI)
Amazon (AMZN)
Metropcs Communications (TMUS)
UnitedHealth (UNH)
Visa Com Cl A (V)
Northrop Grumman Corporation (NOC)
Vanguard Scottsdale Fds Long Term Treas (VGLT)
Astrazeneca Sponsored Adr (AZN)
Charles Schwab Corporation (SCHW)
Genuine Parts Company (GPC)
Apple (AAPL)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)

View all positions for Act Two Investors

Top funds holding AstraZeneca

T. Rowe Price Associates
Wellington Management Company
PRIMECAP Management Company
FMR
Jennison Associates
Franklin Resources
Morgan Stanley
Sanders Capital
Goldman Sachs Group
Fisher Investments
Atlantic Trust
BlackRock
Bank of America Corporation
Holocene Advisors
Neuberger Berman Group

View all funds holding AstraZeneca